By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Spectrum Pharmaceuticals, Inc. 

157 Technology Drive

Irvine  California  92618  U.S.A.
Phone: 949-788-6700 Fax: 949-788-6706




Company News
Spectrum Pharma (SPPI) Highlights Results Of A Combination Study Of FOLOTYN (Pralatrexate Injection) Plus Romidepsin Presented At The 14th International Conference On Malignant Lymphoma (14-ICML) Meeting 6/19/2017 9:05:01 AM
Spectrum Pharma (SPPI) Highlights Three Abstracts Of Clinical Data At The 2017 ASCO Annual Meeting In Chicago, Illinois, June 2-6, 2017 6/2/2017 7:13:12 AM
Spectrum Pharma (SPPI) Reports First Quarter 2017 Financial Results And Pipeline Update 5/3/2017 5:47:09 AM
Spectrum Pharma (SPPI) Announces First Quarter 2017 Financial Results Teleconference And Webcast 4/25/2017 6:24:11 AM
Spectrum Pharma (SPPI) Highlights Preclinical Data Of ROLONTIS (Eflapegrastim) At The AACR Annual Meeting 4/4/2017 7:51:35 AM
Spectrum Pharma (SPPI) Announces Initiation Of A Phase II Trial Of Poziotinib In Non-Small Cell Lung Cancer Patients With EGFR Exon 20 Insertion Mutations 3/30/2017 6:22:41 AM
Spectrum Pharma (SPPI) Reports Fourth Quarter 2016 And Full Year 2016 Financial Results And Pipeline Update 3/9/2017 6:38:05 AM
Spectrum Pharma (SPPI) Announces Fourth Quarter And Full Year 2016 Financial Results Teleconference And Webcast 3/1/2017 6:23:43 AM
Spectrum Pharma (SPPI) Highlights Promising Preclinical Data Evaluating Poziotinib In Lung Cancer At The 17th IASLC World Conference On Lung Cancer 12/8/2016 12:51:46 PM
Spectrum Pharma (SPPI) Highlights Survival Advantage In A Case Match Control Analysis Of The PROPEL Study With FOLOTYN (Pralatrexate Injection) At The 58th Annual Meeting Of American Society of Hematology 12/6/2016 12:30:31 PM